SREBF1 and metabolic dysfunction-associated steatotic liver disease: Overexpression of STAMP2 significantly reduces free FA-induced lipid accumulation, especially in oleic acid-induced NAFLD, by down-regulating adipogenic factors such as SREBP-1.